Skip to main content
2023 SSO Annual Meeting Main banner
  1. Home

ASO Instructions to Contributors: SSO 2023 Accepted Abstracts and the Annals of Surgical Oncology


SSO leadership strongly encourages research presented at SSO’s annual meeting to be published in the Annals of Surgical Oncology (ASO), the official journal of the SSO. The following guidance provides submission information; detailed information will be provided to accepted abstract presenters. 
  • Top 50 Accepted Abstracts. Authors of the top 50 abstracts will be invited to submit their manuscript for consideration for publication in the ASO by December. Identified abstract-manuscript submissions will be targeted for simultaneous publication at the time of abstract presentation. The peer review process can take up to 8 weeks. This invitation will be sent via email from ASO, please look out for this invite with instructions and deadlines.
  • All Other Accepted Abstracts. Authors of all abstracts accepted for oral presentation or poster are strongly encouraged to submit their manuscripts to ASO within three months of the meeting’s conclusion. Manuscript submission information will be posted on the SSO 2023 website.
  • Named Lectureships. Those who are invited to deliver the named lectureships of the International Conference on Surgical Cancer Care are encouraged to submit a manuscript to ASO as a condition of the lectureship. Manuscript submission information will be posted on the SSO 2023 website.

Manuscript Submission

Annals of Surgical Oncology Editorial Office
Email: info@asoeditorial.org
Telephone: 239-217-0704

VISION
Annals of Surgical Oncology is the world’s leading resource for original translational and clinical research, scholarly reviews, and expert opinion in the field of Surgical Oncology.

MISSION
The mission of the journal is to: 1) disseminate high-quality clinical and translational cancer research, review, and expert opinion/commentary articles; 2) represent and advance the profession of Surgical Oncology throughout the world; 3) promote high-quality multidisciplinary patient care worldwide; 4) improve global cancer surgery education and training; and, 5) promote diversity in all of its endeavors.

AUDIENCE
Surgeons, physicians, scientists, and other health care professionals who have a major professional interest and commitment to oncology.

AUTHORSHIP
All authors must have made substantive intellectual contribution to the article for which they are listed on the byline.

The four criteria for authorship defined by the International Committee of Medical Journal Editors are:
  1. substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; and
  2. drafting the work or revising it critically for important intellectual content; and
  3. final approval of the version to be published; and,
  4. agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
DISCLOSURE
Any author affiliation with or financial involvement in any organization with a direct financial interest in the subject matter or materials discussed in the manuscript must be disclosed.

ETHICS
Research, Publication, and Good Practice. All authors are expected to adhere to accepted standards and guidelines for ethical reporting in their submissions to Annals and are referred to the Research ethics, publication ethics and good practice guidelines resource provided by the Equator Network.

A list of best practices and codes of conduct regarding publishing ethics is also provided by Springer.

EXPERIMENTAL SUBJECTS
All authors are expected to abide by accepted ethical standards. In investigations that involve human subjects or laboratory animals, authors should provide an explicit statement in the ‘‘Materials and Methods’’ section that the experimental protocols were approved by the appropriate institutional review committee and meet the guidelines of their responsible governmental agency. In the case of human subjects, informed consent is essential.

New as of January 2021.
Race/Ethnicity Data
Authors who submit studies involving human subjects must report the race/ethnicity distribution of all study participants. These data are typically included in the table presenting a description of study participants. If these data are not provided, authors are required to provide (within the manuscript) an explanation of why this information was not included or is not available.

Visual and Video Abstracts
Submitted original articles must include either a visual abstract or a video abstract, with a brief summary, to be included in the submission’s peer review. If the submission is accepted, the visual abstract or video abstract will be published as a separate, companion accompaniment to the article. Further information is available at https://mc.manuscriptcentral.com/aso.

ORIGINALITY
All manuscripts submitted to Annals must be original; i.e., not published elsewhere (except in abstract form) and not under consideration for publication elsewhere. Annals accepts manuscripts prepared according to the ICJME ‘‘Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals’’ (updated December 2018).

PEER REVIEW
All manuscripts submitted to Annals are subject to peer review. The decision of the Editor-in-Chief and Executive Editor is final. Authors are notified of the decision with reviewer comments if applicable.

Download the complete ASO Instructions to Authors here for specifications regarding Manuscript Preparation and Submission.

Submission Site

Access here: Annals of Surgical Oncology Manuscript Submission Website

BIOMEDICAL JOURNAL STANDARDS AND ANNALS POLICIES
Data Sharing. Annals encourages authors, where possible and applicable, to deposit data that support the findings of their research in a public repository. Authors and editors who do not have a preferred repository should consult Springer Nature’s list of repositories and research data policy.
List of Repositories
Research Data Policy

Reporting of Randomized Trials. The CONSORT (Consolidated Standards of Reporting Trials) Statement offers a standard way for authors to prepare reports of trial findings, facilitating their complete and transparent reporting, and aiding their critical appraisal and interpretation. Authors are recommended to review the following references for further information regarding the CONSORT Statement:
Consensus Statement on Surgery Journal Authorship. In the majority of clinical and research studies submitted to surgery journals for possible publication, many individuals participate in the conception, execution, and documentation of each of those works. However, recognition of work in the form of authorship has varied widely. Authors are recommended to review the following consensus statement for further information regarding these issues regarding surgical journal authorship.
Consensus Statement on Sex-Inclusive Biomedical and Clinical Research.  Annals requires sex-based reporting and analysis for all human and animal studies. If only one sex is studied, the authors must include a justification statement as to why a single-sex study was conducted. For tissue and cell studies, the sexual derivation of tissues or cells must be reported when it is known or should be known; sex-based analysis of results must be performed whenever possible.

This requirement supports a Joint Statement by the Surgery Journal Editors Group:
CONTACT AND FURTHER INFORMATION
Authors are encouraged to contact the Editorial Office for further information (info@asoeditorial.org; 239-217-0704 telephone).
Back to Top